Information provided by
) was the Dow's worst performer, after guiding to full-year earnings well below Wall Street's view. Shares slid 2.6%, in spite of first-quarter earnings that beat expectations and the announcement of a new $15 billion share repurchase program.
The "Big Three" U.S. auto makers all reported double-digit sales gains in April, with Ford
) reporting an 18% increase from the prior year, while General Motors'
) and Chrysler's
) sales both rose about 11%.
) completed its deal with MetroPCS
) to form the new T-Mobile US
), which began trading on the New York Stock Exchange.
Among the notable gainers was Mindspeed Technologies
), up 16% after the company hired Goldman Sachs to review its strategic alternatives and research firm Craig-Hallum said a sale of the company for about $5 per share may be the outcome.
Also higher were shares of Regeneron
), which rose 14% after a potential competitor to its Eylea drug was delayed by Allergan
). Allergan, which also delayed another drug for hair loss and lowered its fiscal 2013 earnings per share guidance, fell 13%.
Another noteworthy loser, Accelrys
), fell 21% after worse-than-expected results prompted downgrades at B. Riley and Sidoti.